# QuantHealth

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/quanthealth

- Industry: Biotechnology
- Headquarters: Tel Aviv, Israel
- Website: www.quanthealth.ai
- Total disclosed funding: $65M
- Latest round: Series B (Aug 4, 2026)
- Investors on record: 16

## About

Based in Tel Aviv, Israel, and founded in 2020, QuantHealth Ltd operates as a clinical trial company that offers services like drug simulation, computational biology, and oncology services. The company was founded by its CEO Orr Inbar. In August 2026, QuantHealth Ltd. raised USD 45 million in series B funding led by Qumra Capital, with participation from ArtofIn Venture Capital Fund, Esplanade HealthTech Ventures, GC Ventures, NewHealth Ventures, Bertelsmann Investments, Pitango, Sanofi Ventures, Shoni Health Ventures. The company will use the funding to expand research and development, grow its team, and broaden its clinical trial simulation products.

The company uses algorithms to develop real-world simulations by using more than 1 trillion data points in clinical and pharmacological domains. These data points help the firm to develop a clinical trial simulator which helps clinical development and clinical operations teams to stimulate clinical trials. The platform offered by the firm helps therapy and drug development companies to see how the therapy will perform in real life.

## Funding rounds

- Series B, Aug 4, 2026, $45M — Pitango, Sanofi Ventures, Qumra Capital, Esplanade HealthTech Ventures, GC Ventures, Bertelsmann Investments, ArtofIn Venture Capital Fund, Shoni Health Ventures
- Series A, Jan 8, 2024, $2M — Accenture Technology Ventures
- Series A, Aug 30, 2023, $15M — Boston Millennia Partners, Pitango, Nova Capital, Atooro Fund, Nina Capital, Renegade Ventures, Bertelsmann Investments, Shoni Health Ventures
- Seed, Oct 26, 2022, $2.6M — Pitango, Bessemer Venture Partners, Atooro Fund, Nina Capital, Millenia Partners

## Investors

- Pitango (https://capitalatlas.ai/funds/pitango) — Seed, Series A, Series B
- Bessemer Venture Partners (https://capitalatlas.ai/funds/bessemer-venture-partners) — Seed
- Atooro Fund (https://capitalatlas.ai/funds/atooro-fund) — Seed, Series A
- Nina Capital (https://capitalatlas.ai/funds/nina-capital) — Seed, Series A
- Millenia Partners — Seed
- Boston Millennia Partners (https://capitalatlas.ai/funds/boston-millennia-partners) — Series A
- Nova Capital — Series A
- Renegade Ventures — Series A
- Bertelsmann Investments (https://capitalatlas.ai/funds/bertelsmann-investments) — Series A, Series B
- Shoni Health Ventures (https://capitalatlas.ai/funds/shoni-health-ventures) — Series A, Series B
- Accenture Technology Ventures (https://capitalatlas.ai/funds/accenture-technology-ventures) — Series A
- Sanofi Ventures (https://capitalatlas.ai/funds/sanofi-ventures) — Series B
- Qumra Capital (https://capitalatlas.ai/funds/qumra-capital) — Series B
- Esplanade HealthTech Ventures (https://capitalatlas.ai/funds/esplanade-healthtech-ventures) — Series B
- GC Ventures — Series B
- ArtofIn Venture Capital Fund (https://capitalatlas.ai/funds/artofin-venture-capital-fund) — Series B